Filana Therapeutics, Inc. Interest Receivable, Current
Filana Therapeutics, Inc. (FLNA) had Interest Receivable, Current of $117.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Nontrade Receivables, Current
us-gaap:InterestReceivableCurrent · last filed 2026-05-07
- 2026-03-31: Interest Receivable, Current $117.00K.
- 2025-12-31: Interest Receivable, Current $120.00K.
- 2025-09-30: Interest Receivable, Current $817.00K.
- 2025-06-30: Interest Receivable, Current $835.00K.
| Period end | Interest Receivable, Current | Interest Receivable, Current as first filed |
|---|---|---|
| 2026-03-31 | $117.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $120.00K 10-Q · filed 2026-05-07 | |
| 2025-09-30 | $817.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $835.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $864.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $947.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $1.27M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.43M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.00M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $962.00K 10-K · filed 2025-03-03 | |
| 2023-09-30 | $1.28M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $962.00K 10-Q · filed 2024-08-08 | $1.33M 10-Q · filed 2023-08-03 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 | |
| 2019-12-31 | $29.00K 10-Q · filed 2020-11-09 | |
| 2014-12-31 | $10.00K 10-K · filed 2016-03-03 | |
| 2012-06-30 | $83.00K 10-Q · filed 2012-08-02 | |
| 2011-12-31 | $276.00K 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |